Using the rate of bacterial clearance determined by real-time polymerase chain reaction as a timely surrogate marker to evaluate the appropriateness of antibiotic usage in critical patients with Acinetobacter baumannii bacteremia

被引:26
作者
Chuang, Yu-Chung [2 ]
Chang, Shan-Chwen [2 ]
Wang, Wei-Kung [1 ]
机构
[1] Univ Hawaii, John A Burns Sch Med, Dept Trop Med, Honolulu, HI 96822 USA
[2] Natl Taiwan Univ, Coll Med, Dept Internal Med, Inst Microbiol, Taipei, Taiwan
关键词
Acinetobacter baumannii; appropriate antibiotics; bacteremia; critical care; rate of bacterial clearance; MORTALITY; EPIDEMIOLOGY; RESISTANCE; PCR;
D O I
10.1097/CCM.0b013e3182515190
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: Bacteremia caused by Acinetobacter baumannii is becoming more frequent among critically ill patients, and has been associated with high mortality and prolonged hospital stay. Multidrug resistance and delay in blood culture have been shown to be significant barriers to appropriate antibiotic treatment. Quantitative polymerase chain reaction assays were recently used to monitor bacterial loads; we hypothesized that the rate of bacterial clearance determined by quantitative polymerase chain reaction can be used as a timely surrogate marker to evaluate the appropriateness of antibiotic usage. Design: Prospective observational study. Setting: University hospital and research laboratory. Patients: Patients with culture-proven A. baumannii bacteremia in the intensive care units were prospectively enrolled from April 2008 to February 2009. Interventions: Plasmid Oxa-51/pCRII-TOPO, which contained a 431-bp fragment of the A. baumannii-specific Oxa-51 gene in a pCRII-TOPO vector, was used as the standard. Sequential bacterial DNA loads in the blood were measured by a quantitative polymerase chain reaction assay. Measurements and Main Results: We enrolled 51 patients with A. baumannii bacteremia, and examined 318 sequential whole blood samples. The initial mean bacterial load was 2.15 log copies/mL, and the rate of bacterial clearance was 0.088 log copies/mL/day. Multivariate linear regression using the generalized estimation equation approach revealed that the use of immunosuppressants was an independent predictor for slower bacterial clearance (coefficient, 1.116; p < .001), and appropriate antibiotic usage was an independent predictor for more rapid bacterial clearance (coefficient, -0.995; p < .001). Patients with a slower rate of bacterial clearance experienced higher in-hospital mortality (odds ratio, 2.323; p = .04) Conclusions: Immunosuppression and appropriate antibiotic usage were independent factors affecting the rate of clearance of A. baumannii bacteremia in critical patients. These findings highlight the importance of appropriate antibiotic usage and development of effective antibiotics against A. baumannii in an era of emerging antibiotic resistance. The rate of bacterial clearance could serve as a timely surrogate marker for evaluating the appropriateness of antibiotics. (Crit Care Med 2012; 40:2273-2280)
引用
收藏
页码:2273 / 2280
页数:8
相关论文
共 37 条
[1]  
[Anonymous], MANUAL CLIN MICROBIO
[2]   Reliability of the E-test method for detection of colistin resistance in clinical isolates of Acinetobacter baumannii [J].
Arroyo, LA ;
García-Curiel, A ;
Pachón-Ibañez, ME ;
Llanos, AC ;
Ruiz, M ;
Pachón, J ;
Aznar, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (02) :903-905
[3]   Severe bacteremia results in a loss of hepatic bacterial clearance [J].
Ashare, A ;
Monick, MM ;
Powers, LS ;
Yarovinsky, T ;
Hunninghake, GW .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 173 (06) :644-652
[4]   Chronic Liver Disease Impairs Bacterial Clearance in a Human Model of Induced Bacteremia [J].
Ashare, Alix ;
Stanford, Clark ;
Hancock, Patricia ;
Stark, Donna ;
Lilli, Kathleen ;
Birrer, Emily ;
Nymon, Amanda ;
Doerschug, Kevin C. ;
Hunninghake, Gary W. .
CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2009, 2 (03) :199-205
[5]  
Chen Hsin-Pai, 2005, Journal of Microbiology Immunology and Infection, V38, P127
[6]   Influence of Genospecies of Acinetobacter baumannii Complex on Clinical Outcomes of Patients with Acinetobacter Bacteremia [J].
Chuang, Yu-Chung ;
Sheng, Wang-Huei ;
Li, Shu-Ying ;
Lin, Yu-Chi ;
Wang, Jann-Tay ;
Chen, Yee-Chun ;
Chang, Shan-Chwen .
CLINICAL INFECTIOUS DISEASES, 2011, 52 (03) :352-360
[7]   High and Increasing Oxa-51 DNA Load Predict Mortality in Acinetobacter baumannii Bacteremia: Implication for Pathogenesis and Evaluation of Therapy [J].
Chuang, Yu-Chung ;
Chang, Shan-Chwen ;
Wang, Wei-Kung .
PLOS ONE, 2010, 5 (11)
[8]   Bacteremia due to Acinetobacter baumannii epidemiology, clinical findings, and prognostic features [J].
Cisneros, JM ;
Reyes, MJ ;
Pachon, J ;
Becerril, B ;
Caballero, FJ ;
GarciaGarmendia, JL ;
Ortiz, C ;
Cobacho, AR .
CLINICAL INFECTIOUS DISEASES, 1996, 22 (06) :1026-1032
[9]  
Clinical and Laboratory Standards Institute, 2007, M100S17 CLSI
[10]   Impact of early appropriate antimicrobial therapy on survival in Acinetobacter baumannii bloodstream infections [J].
Erbay, Ayse ;
Idil, Aysun ;
Gozel, M. Goekhan ;
Mumcuoglu, Ipek ;
Balaban, Neriman .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2009, 34 (06) :575-579